Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07070583

Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure

Led by Rijnstate Hospital · Updated on 2026-04-03

20

Participants Needed

1

Research Sites

91 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Hypertension is a major risk factor for a variety of cardiovascular diseases. When hypertension results from increased vascular resistance due to a narrowing of the descending aorta, it can be effectively treated with stenting. More recently, evidence suggest that stenting in more distal parts of the arterial vascular bed is also associated with a reduction in blood pressure. The investigators hypothesize that stenting of occlusions more distal of the descending aorta decreases the central blood pressure and afterload as reflected by NT-proBNP (N-terminal pro-Brain Natriuretic Peptide), a biomarker of intracardiac pressures and predictor of heart failure events. The goal of this pilot study is to prospectively investigate changes in blood pressure after stent placement in the aorto-iliac region.

CONDITIONS

Official Title

Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age �38 years
  • Signed informed consent
  • Chronic occlusion in the infrarenal aorta and/or one or both common iliac arteries
  • Total lesion length of �30mm or more
  • Clinical indication for treatment such as chronic limb threatening ischemia or disabling intermittent claudication not responding to supervised exercise training
Not Eligible

You will not qualify if you...

  • Unable to understand study requirements or unwilling to adhere to follow-up
  • Juxtarenal pathology less than 2 cm below the lowest renal artery
  • Acute occlusion of the target area (Acute Leriche Syndrome)
  • Embolic disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Rijnstate

Arnhem, Netherlands, 6815AD

Actively Recruiting

Loading map...

Research Team

M

Michel Reijnen, prof.dr.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here